Products Categories
CAS No.: | 149-16-6 |
---|---|
Name: | BUTACAINE |
Molecular Structure: | |
Formula: | C18H30 N2 O2 |
Molecular Weight: | 306.448 |
Synonyms: | 1-Propanol,3-(dibutylamino)-, 4-aminobenzoate (ester) (9CI); 1-Propanol,3-(dibutylamino)-, p-aminobenzoate (7CI); 1-Propanol, 3-(dibutylamino)-,p-aminobenzoate (ester) (8CI); Butacaine (6CI); 3-(Dibutylamino)-1-propanolp-aminobenzoate; 3-(p-Aminobenzoxy)-1-di-n-butylaminopropane;3-Dibutylaminopropyl p-aminobenzoate; Butelline; Butyn |
Density: | 1.014g/cm3 |
Melting Point: | 25°C |
Boiling Point: | 440°C at 760 mmHg |
Flash Point: | 219.9°C |
Safety: | A poison via subcutaneous and intravenous routes. A weak allergen. Combustible. When heated to decomposition it emits toxic fumes of NOx. See also BUTACAINE SULFATE. |
PSA: | 55.56000 |
LogP: | 4.29910 |
Chemistry informtion about Butacaine(CAS NO.149-16-6) is:
IUPAC Name: 3-(dibutylamino)propyl 4-aminobenzoate
Synonyms: 1-Propanol, 3-(dibutylamino)-, 4-aminobenzoate ; 1-Propanol, 3-(dibutylamino)-, 4-aminobenzoate (ester) ; 1-Propanol, 3-(dibutylamino)-, p-aminobenzoate ; 1-Propanol, 3-(dibutylamino)-, p-aminobenzoate (ester) ; 3-(Dibutyamino)-1-propanol-p-aminobenzoate (ester) ; 3-(dibutylamino)-1-propano4-aminobenzoate(ester) ; 3-(Dibutylamino)-1-propanol p-aminobenzoate ; 3-(dibutylamino)-1-propanolp-aminobenzoate
Molecular Weight: 306.443 [g/mol]
Molecular Formula: C18H30N2O2
XLogP3: 4.5
H-Bond Donor: 1
H-Bond Acceptor: 4
EINECS: 205-734-7
Density: 1.014 g/cm3
Flash Point: 219.9 °C
Enthalpy of Vaporization: 69.7 kJ/mol
Boiling Point: 440 °C at 760 mmHg
Vapour Pressure: 6.1E-08 mmHg at 25°C
Storage temp.: −20°C
Following is the molecular structure of Butacaine(CAS NO.149-16-6) is:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LDLo | intravenous | 15mg/kg (15mg/kg) | American Journal of Physiology. Vol. 68, Pg. 110, 1924. | |
cat | LDLo | subcutaneous | 30mg/kg (30mg/kg) | behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation lungs, thorax, or respiration: other changes | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. |
dog | LDLo | subcutaneous | 55mg/kg (55mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
frog | LDLo | intraspinal | 30mg/kg (30mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 45, Pg. 291, 1932. | |
guinea pig | LDLo | subcutaneous | 45mg/kg (45mg/kg) | peripheral nerve and sensation: flaccid paralysis without anesthesia (usually neuromuscular blockage) behavioral: convulsions or effect on seizure thresholdbehavioral: changes in motor activity (specific assay) | Journal of Pharmacology and Experimental Therapeutics. Vol. 62, Pg. 69, 1938. |
mouse | LDLo | intravenous | 12mg/kg (12mg/kg) | Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 4, 1950. | |
mouse | LDLo | subcutaneous | 50mg/kg (50mg/kg) | Journal of the American Chemical Society. Vol. 61, Pg. 3562, 1939. | |
rabbit | LDLo | intravenous | 12mg/kg (12mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
rabbit | LDLo | subcutaneous | 50mg/kg (50mg/kg) | behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation lungs, thorax, or respiration: other changes | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. |
rat | LDLo | intravenous | 7500ug/kg (7.5mg/kg) | Physiological Reviews. Vol. 12, Pg. 190, 1932. | |
rat | LDLo | subcutaneous | 150mg/kg (150mg/kg) | behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: respiratory stimulation lungs, thorax, or respiration: other changes | Journal of Pharmacology and Experimental Therapeutics. Vol. 24, Pg. 167, 1925. |
A poison via subcutaneous and intravenous routes. A weak allergen. Combustible. When heated to decomposition it emits toxic fumes of NOx. See also BUTACAINE SULFATE.
RIDADR: 3249
WGK Germany: 3
RTECS: UB0875000
HazardClass: 6.1(b)
PackingGroup: III
Butacaine(CAS NO.149-16-6) is a local anesthetic.